Twelve subjects with minimal expression of the myotonic dystrophy (MyD) 
Myotonic dystrophy (MyD) or CurschmannSteinert disease is an autosomal dominant multisystem disorder of which the gene abnormality is localised on chromosome 19. 2 DNA diagnosis of MyD is possible with both sensitivity and specificity higher than 96%.2 It shows variable gene penetrance and expressivity, and the onset of MyD varies from early infancy to old age. 3 An alteration in the intrinsic biochemical composition of the cell membrane, affecting the entire body, has been proposed as the pathogenesis of MyD. ' Ocular abnormalities associated with MyD are cataract, hypotonia, and chorioretinal changes. Several authors reported the considerable electroretinal alterations in MyD patients, even before futidal changes and other expression ofthe abnormal gene."'4 A common finding was the reduction of the b-wave amplitude in the electroretinogram (ERG) both in scotopic and photopic conditions.i 12 Visual evoked potential (VEP) recording in MyD repeatedly showed prolongation of latency or decrease of amplitude. 12 Recordings of the pattern ERG (PERG) and pattern VEP (pVEP) simultaneously demonstrated abnormalities that occurred independently of one another. The authors also found subnormal electro-oculogram Arden indices.
They suggested that the pathological process may affect both the retina and post-retinal intrin group.bmj.com on July 7, 2017 -Published by http://bjo.bmj.com/ Downloaded from oscillations at the basal membrane, the concentration of the 'light peak substance (lps)' at the level of the photoreceptors or the transmittance of the message across the apical membrane through the RPE cytoplasm to the basal membrane. Less likely hypotheses we cannot exclude are a delay or a block in the messenger system or a defective voltage generation system of RPE and photoreceptors, similar to the one demonstrated in the muscle and erythrocyte membranes. Nevertheless, the 'lps' concentration change abnormality at the level of the photoreceptors32 might explain both ERG, EOG, and densitometry findings. Therefore, we postulate an abnormality in a Na, Ca:K dependent exchanger in the outer segments to be the primary defect, taking into account knowledge of membrane pathophysiology. The mRNA of the MyD gene encodes a protein kinase polypeptide, which is known to modulate the activity of excitable cells by phosphorylation of ion channels.33" The (muscle) membrane has a decreased resting potential, with a value close to the threshold for activation of Na+ channels and the presence of specific (apamin sensitive) Ca2`activated K+ channels.35 3 Besides, the Na+-K+-ATPase activity is decreased and the voltage dependent Ca2`channels are active under conditions in which they are normally inactive.37 Therefore, instead of 3 moles of Na+ ion exchange for 2 moles ofK+ ion in control cells, a 2 Na+ for 2 K+ ion exchange occurred in MyD cells.38 Altered inward sodium transport and extracellular leaking of potassium is involved in the generation of action potentials or regulation of resting potentials.3 ' The defective regulation of ion transport could initiate or contribute to abnormal cellular functions in MyD.4" Remarkably, in more advanced disease the Mueller glial cell becomes affected. In particular this cell, with a high resting potential, appears to be most sensitive to potassium changes at physiological levels compared with neurons. 42 We hope that future studies may obtain additional information on the locality and mechanisms of the retinal dysfunction in MyD.
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